Current Studies
Browse our actively enrolling clinical research studies. No cost to participate. All studies are IRB-approved.
Evaluating a once-weekly injectable therapy versus standard oral medication for adults with T2D. 52-week study at multiple sites.
Investigating an immunotherapy combination for patients recently diagnosed with Stage I–II non-small cell lung cancer.
Testing a CGRP-targeting monthly injection against placebo for adults experiencing 15+ migraine days per month.
Examining a novel oral antidepressant with rapid onset in adults who haven't responded to two prior treatments.
Long-term safety and efficacy monitoring of an approved biologic in patients with moderate-to-severe RA on stable therapy.
Comparing two biologic therapies head-to-head in adults with moderate-to-severe plaque psoriasis covering 10%+ body surface area.